Regulation of MLK3 by LATS
Regulation of MLK3 by LATS
批准号:
10056321
负责人:
Deborah N Chadee
金额:
$15.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2023-08-31
关键词:
AffectBindingBreast Cancer CellCell AdhesionCell NucleusCell PolarityCell Surface ReceptorsCellsCharacteristicsDevelopmentE-CadherinEpithelialEpithelial CellsEpitheliumLATS1 geneMalignant neoplasm of ovaryMediatingMesenchymalMitogen-Activated Protein KinasesNuclearPhosphorylationProcessPropertyRegulationSKOV3 cellsSignal PathwaySignal TransductionSmall Interfering RNAVimentinbeta-Transducin Repeat-Containing Proteinscancer cellcancer therapycell transformationepithelial to mesenchymal transitionextracellular signal-regulated kinase 4knock-downmetaplastic cell transformationmigrationmixed lineage kinase 3protein degradationrecruittransmission processtumor progressiontumorigenesis
中文摘要
摘要
混合谱系激酶3和4是调节MAPK的丝裂原活化蛋白激酶(MAPK)
信号通路,并介导信号从细胞表面受体到
原子核。MLK3和MLK4在卵巢癌的侵袭和迁移中具有重要作用
乳腺癌细胞。上皮间充质转化(EMT)是上皮细胞
细胞失去细胞极性和粘附性,获得迁移和侵袭性
间充质细胞的特性。EMT的异常激活可促进细胞
转化和癌症进展。了解EMT是如何监管的对于
开发新的癌症治疗方法。由于它们在细胞转化中的作用,我们
推测MLK3和MLK4可能是卵巢EMT过程的重要调节因子
癌细胞。利用siRNA敲除SKOV3中MLK3和MLK4的初步发现
卵巢癌细胞提示MLK3或MLK4的缺失会影响EMT标志物E-
钙粘附素和波形蛋白。我们认为MLK3和MLK4是EMT的重要调节器,并且
当在卵巢癌细胞中异常调节时,促进EMT进展、侵袭和
肿瘤发生学。在本研究中,我们将研究MLK3和MLK4的作用机制
调节关键EMT标志物的表达,控制卵巢癌球体的形成和
入侵。
英文摘要
Abstract
Mixed lineage kinase 3 and 4 are mitogen-activated protein kinases (MAPKs) that regulate MAPK
signaling pathways, and mediate transmission of signals from cell surface receptors to the
nucleus. MLK3 and MLK4 have important functions in invasion and migration of ovarian and
breast cancer cells. Epithelial mesenchymal transition (EMT) is the process by which epithelial
cells lose cell polarity and adhesion properties and acquire the migratory and invasive
characteristics of mesenchymal cells. Aberrant activation of EMT can contribute to cell
transformation and cancer progression. Understanding how EMT is regulated is important for
development of new cancer treatments. Due to their functions in cellular transformation, we
hypothesized that MLK3 and MLK4 could be important regulators of the EMT process in ovarian
cancer cells. Our preliminary findings using siRNA knockdown of MLK3 and MLK4 in SKOV3
ovarian cancer cells indicate that loss of MLK3 or MLK4 affects the levels of EMT markers, E-
cadherin and vimentin. We propose that MLK3 and MLK4 are important modulators of EMT, and
when aberrantly regulated in ovarian cancer cells, promote EMT progression, invasion and
tumorigenesis. In the current study, we will investigate the mechanisms by which MLK3 and MLK4
regulate the expression of key EMT markers, and control ovarian cancer spheroid formation and
invasion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Cadherins by MLK3
-
批准号:10793060
-
项目类别:
-
资助金额:$45.15万
-
财政年份:2023
-
负责人:Deborah N Chadee
-
依托单位:
Regulation of MLK3 by LATS
-
批准号:9811718
-
项目类别:
-
资助金额:$45.07万
-
财政年份:2019
-
负责人:Deborah N Chadee
-
依托单位:
Regulation of MLK3 by oxidative stress in colon cancer cells
-
批准号:9097305
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2016
-
负责人:Deborah N Chadee
-
依托单位:
MLK4 regulation of MAPK signaling
-
批准号:8366331
-
项目类别:
-
资助金额:$34.92万
-
财政年份:2012
-
负责人:Deborah N Chadee
-
依托单位:
Regulation of Mixed Lineage Kinase 3 by the tumor suppressor protein Merlin
-
批准号:7364459
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2008
-
负责人:Deborah N Chadee
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: